AAHKS最佳口头报告研究奖:第二剂地塞米松减少全关节置换术后阿片类药物消耗与疼痛
该回顾性队列研究纳入2020年5月至2021年4月间2256例初次择期全髋关节置换术(THA)和1951例初次择期全膝关节置换术(TKA)患者,将接受2剂围手术期地塞米松10 mg静脉注射(2D)的患者与接受1剂(1D)的患者按1:1倾向性匹配。结果显示2D组在术后24至48小时和48至72小时 intervals 阿片类药物消耗显著减少,TKA 2D组总阿片消耗显著降低,且2D组在48至60小时疼痛评分显著更低,功能恢复(AM-PAC)无差异。
要点
- 第二剂地塞米松显著减少THA和TKA术后24-48小时及48-72小时的阿片类药物消耗。
- 2D TKA组总阿片消耗显著低于1D TKA组。
- 2D组在48-60小时疼痛评分显著更低,TKA 2D组在36-48小时也显著更低,功能恢复无差异。
核心结论
- 围手术期第二剂地塞米松显著减少术后早期阿片类药物消耗,在维持相当功能恢复的同时实现更优疼痛控制。
研究设计与样本
- 回顾性队列研究,纳入2020年5月至2021年4月间2256例初次择期THA和1951例初次择期TKA患者,将接受2剂地塞米松10 mg IV(2D)的患者与接受1剂(1D)的患者按1:1倾向性匹配。
主要发现
- 2D THA和2D TKA队列在24至48小时及48至72小时 intervals 阿片消耗显著少于1D队列。
- 2D TKA队列总阿片消耗显著低于1D TKA队列。
- 2D THA和2D TKA队列在48至60小时疼痛评分显著低于1D队列,2D TKA队列在36至48小时疼痛评分也显著更低。
- TKA和THA的AM-PAC评分在各时间 intervals 组间均无差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The optimal administration of dexamethasone for postoperative pain management and recovery following primary elective total joint arthroplasty (TJA) remains unclear. This study aimed to evaluate the effect of a second intravenous (IV) dose of dexamethasone on postoperative pain scores, inpatient opioid consumption, and functional recovery after total hip arthroplasty (THA) and total knee arthroplasty (TKA). METHODS: A retrospective review was conducted of 2,256 primary elective THAs and 1,951 primary elective TKAs between May 2020 and April 2021. Patients who received 2 perioperative doses (2D) of dexamethasone 10 mg IV were propensity-matched 1:1 to a control group who received 1 perioperative dose (1D). Primary outcomes were opiate consumption as morphine milligram equivalences (MMEs), postoperative pain as Verbal Rating Scale (VRS) pain scores, and functional status assessed by the Activity Measure for Post-Acute Care (AM-PAC) scores. RESULTS: The 2D THA and 2D TKA cohorts consumed significantly less opiates at the 24 to 48-hour and 48 to 72-hour intervals. The 2D TKA cohort had significantly lower total opiate consumption compared to the 1D TKA cohort. Compared to the 1D cohorts, the 2D THA cohort and 2D TKA cohorts had significantly lower pain scores at the 48 to 60-hour interval; additionally, the 2D TKA cohort had significantly lower pain scores in the 36 to 48-hour interval. AM-PAC scores did not differ between cohorts for both TKA and THA at any interval. CONCLUSION: The administration of a second perioperative dexamethasone dose significantly decreased opioid consumption in the immediate postoperative period. Inpatient opioid administration can be significantly reduced while maintaining comparable functional recovery and superior pain control. LEVEL III EVIDENCE: Retrospective Cohort Study.
引用
- Arraut J, Thomas J, Oakley CT, et al. The AAHKS Best Podium Presentation Research Award: A Second Dose of Dexamethasone Reduces Postoperative Opioid Consumption and Pain in Total Joint Arthroplasty. J Arthroplasty. 2023. PMID: 36775214. doi:10.1016/j.arth.2023.02.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。